[1] Defacque H, Egeberg M, Habermann A, et al. Involvement of ezrin/moesin in de novo actin assembly on phagosomal membranes[J]. EMBO J, 2000, 19(2): 199-212.
[2] Dard N, Louvet S, SantaMaria A, et al. In vivo functional analysis of ezrin during mouse blastocyst formation[J]. Dev Biol, 2001, 233(1): 161-173.
[3] 李佩玲, 胡春杰, 李长民, 等. 脂质体介导的DCC基因对卵巢上皮性癌细胞生长的抑制作用[J]. 中华妇产科杂志, 2006, 41(3): 186-189.
[4] Martin M, SimonAssmann P, Kedinger M, et al. DCC regulates cell adhesion in human colon cancer derived HT29 cells and associates with ezrin[J]. Eur J Cell Biol, 2010, 85(8): 769-783.
[5] Dickson TC, Mintz CD, Benson DL, et al. Functional binding interaction identified between the axonal CAM L1 and members of the ERM family[J]. J Cell Biol, 2002, 157(7): 1105-1112.
[6] Elliott BE, Meens JA, SenGupta SK, et al. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells[J]. Breast Cancer Res, 2005, 7(3): R365-373.
[7] Forcet C, Stein E, Pays L, et al. Netrin1mediated axon outgrowth requires deleted in colorectal cancerdependent MAPK activation[J]. Nature, 2002, 41(7): 443-447.
[8] Gautreau A, Louvard D, Arpin M. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling[J]. Curr Opin Cell Biol, 2002, 14(1): 104-109. |